Glaucoma is a slowly progressing eye disease caused by damage to the optic disc and this can lead to permanent peripheral vision impairment if not treated. 

Our recent diagnostic accuracy study (the GATE study), evaluated whether automated imaging technologies can be used to aid glaucoma diagnosis in hospital services and recruited nearly 1000 patients who had been newly referred for possible glaucoma. 

The PEG study, funded by the International Glaucoma Association, aims to understand more about what happens to patients’ vision after their referral from the community as they are monitored or treated in hospital eye services.  PEG will investigate the progression of glaucoma in a subset of the GATE cohort who had glaucoma or were diagnosed as at risk of glaucoma (glaucoma suspects and ocular hypertension) over 4 years of routine monitoring and treatment in hospital eye services.  We will investigate whether any of the characteristics of the person (e.g. age, gender, intraocular pressure, measurements of the retina and optic disc taken at baseline from the GATE study) can predict which patients will have progressive disease.


Katie Banister


Writing up - Dissemination ongoing